Personalis at Precision: Breast Cancer Summit: June 16-17, 2020

Presentation

Christelle Johnson, PhD
Senior Field Application Scientist

Tuesday, June 16 | 10:15 AM

Enabling multidimensional tumor immunogenomics for advancing biomarker discovery 

  • Insight into the complex and dynamic interactions between the tumor and immune cells of the microenvironment is essential for cancer immunotherapy translational studies
  • Purpose built for precision oncology, the ImmunoID NeXT Platform investigates key areas of tumor biology; from elucidating mechanisms of tumor escape and detecting neoantigens, to identifying novel signatures and characterizing the immune repertoire
  • We’ll discuss the current challenges facing investigators in immuno-oncology translational research including maximizing data generation from a single sample and enabling composite biomarker discovery

Visit our exhibit at Precision: Breast Cancer Summit 2020